Pharmacodynamic comparisons of antimicrobials against nosocomial isolates of escherichia coli, klebsiella pneumoniae, acinetobacter baumannii and pseudomonas aeruginosa from the MYSTIC surveillance program: the OPTAMA Program, South America 2002

This publication has 23 references indexed in Scilit:

• Effectiveness of Combination Antimicrobial Therapy for Pseudomonas aeruginosa Bacteremia
  Antimicrobial Agents and Chemotherapy, 2003
• Prevention of Resistance: A Goal for Dose Selection for Antimicrobial Agents
  Clinical Infectious Diseases, 2003
• Use of Preclinical Data for Selection of a Phase II/III Dose for Evernimicin and Identification of a Preclinical MIC Breakpoint
  Antimicrobial Agents and Chemotherapy, 2001
• The use of Monte Carlo simulation to examine pharmacodynamic variance of drugs: fluoroquinolone pharmacodynamics against Streptococcus pneumoniae
  Diagnostic Microbiology and Infectious Disease, 2000
• Pharmacodynamics in the study of drug resistance and establishing in vitro susceptibility breakpoints: ready for prime time
  Current Opinion in Microbiology, 2000
• Bacterial Resistance: A Worldwide Problem
  Diagnostic Microbiology and Infectious Disease, 1998
• State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and Men
  Clinical Infectious Diseases, 1998
• The emergent needs for basic research, education, and surveillance of antimicrobial resistance: Problems facing the report from the American Society for Microbiology task force on antibiotic resistance
  Diagnostic Microbiology and Infectious Disease, 1996
• Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients
  Antimicrobial Agents and Chemotherapy, 1993
• STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
  The Lancet, 1986